Correlation Between Pfizer and PGIM Large

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and PGIM Large at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and PGIM Large into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and PGIM Large Cap Buffer, you can compare the effects of market volatilities on Pfizer and PGIM Large and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of PGIM Large. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and PGIM Large.

Diversification Opportunities for Pfizer and PGIM Large

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and PGIM is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and PGIM Large Cap Buffer in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PGIM Large Cap and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with PGIM Large. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PGIM Large Cap has no effect on the direction of Pfizer i.e., Pfizer and PGIM Large go up and down completely randomly.

Pair Corralation between Pfizer and PGIM Large

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the PGIM Large. In addition to that, Pfizer is 5.49 times more volatile than PGIM Large Cap Buffer. It trades about -0.08 of its total potential returns per unit of risk. PGIM Large Cap Buffer is currently generating about 0.17 per unit of volatility. If you would invest  2,510  in PGIM Large Cap Buffer on September 3, 2024 and sell it today you would earn a total of  165.00  from holding PGIM Large Cap Buffer or generate 6.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy28.08%
ValuesDaily Returns

Pfizer Inc  vs.  PGIM Large Cap Buffer

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
PGIM Large Cap 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in PGIM Large Cap Buffer are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, PGIM Large is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pfizer and PGIM Large Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and PGIM Large

The main advantage of trading using opposite Pfizer and PGIM Large positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, PGIM Large can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PGIM Large will offset losses from the drop in PGIM Large's long position.
The idea behind Pfizer Inc and PGIM Large Cap Buffer pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals